Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Anticancer compound from AEterna enters the clinic

Nov. 29, 1996

3DP seeks partners for potential treatments for retinopathies and cancer

Nov. 29, 1996

Novel nonmacrolide antitumor agent discovered by Mitsubishi

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

New market introduction for antiestrogen

Nov. 28, 1996

New 5-FU formulation reduces toxicity in mice

Nov. 28, 1996

Exclusive worldwide rights offered for human full-length TRK-B

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026